The International Society for Aerosols in Medicine (ISAM) was founded in 1970. The objectives of ISAM are to stimulate and further the interdisciplinary cooperation and exchange of information in all aspects of aerosol research in medicine including health effects of inhaled aerosols and pulmonary drug delivery.
The International Society for Aerosols in Medicine (ISAM) is proud to announce that the 21st Congress will be held in Santa Fe, NM from 03 to 07 June 2017. The congress will bring together nearly 400 international attendees at one of the largest pulmonary drug delivery and respiratory health conferences. The attendees will include clinicians, respiratory health care professional, aerosol engineers, formulations scientists and regulatory representatives.
The scientific agenda will be focused on the current state of the art understanding of pulmonary disease, environmental aerosols, device/formulation strategies, advancing imaging techniques and emerging aerosol technologies. Preceding the conference will be continuing educational classes focused on preclinical respiratory drug delivery, environmental exposures and current regulatory updates. The objective of all portions of the congress will be to foster scientific discussions around the current state of the art for aerosols in medicine.
The success of the 21st ISAM Congress relies on sponsorship from leading companies within aerosols in medicine. As a sponsor of ISAM 2017 you will have the opportunity to showcase your company / scientific expertise / emerging technologies within one of the premier scientific meetings focused on aerosols within medicine. Included herein are details on different sponsorship opportunities and details as to the potential exposure this venue will provide for your company.
Please consider sponsorship and attendance at the 21st ISAM Congress in June 2017. If you have any questions please reach out to any of the conference organizers (Philip Kuehl or Matt Reed).
|Matthew Reed, PhD, DABT||Philip Kuehl, PhD